T1	intervention 0 22	Inulin Supplementation
T2	condition 31 54	Systolic Blood Pressure
T3	eligibility 688 755	women with early-stage breast cancer undergoing neoadjuvant therapy
T4	No-of-participants 759 761	38
T5	control 879 901	placebo (maltodextrin)
T6	duration 906 913	21 days
T7	outcome-Measure 915 950	Body composition and blood pressure
T8	outcome 1052 1081	systolic blood pressure (SBP)
T9	outcome 1189 1219	Diastolic blood pressure (DBP)
T10	outcome 1306 1309	BMI
T11	outcome 1332 1335	BFP
